My Companies
Notification
Account
Log Out
Login
RPG Active Pharma agreed to acquire Raghava Life Sciences’ API/intermediates business for up to ₹135 crore, adding a 300 KL EU-GMP facility, 22 commercialized APIs and seven under development, subject to approvals and closing conditions. Context: prolonged M&A optionality is now shifting toward integration execution.
RPG Life Sciences Partners With InvAscent In ₹243.33 Crore API Investment
RPG Life Sciences Approves Up To ₹135 Crore Raghava API Acquisition
RPG Life Sciences Approves ₹135 Crore API Business Acquisition
RPG Life Sciences Carves Out API Business, Raises ₹243 Crore From InvAscent
RPG Life Sciences Approves ₹243 Crore API Subsidiary Investment And Acquisition